Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

News From Washington: IOM report says safety issues point to FDA fund 'imbalance'

Oct. 5, 2006

By Aaron Lorenzo

MacroGenics Gets $63M From Government, Mostly For WNV

Oct. 4, 2006

By Aaron Lorenzo

Gamida Cell Raises $16M To Broaden Its Programs

Oct. 4, 2006

By Aaron Lorenzo

Gamida Cell Raises $16M To Broaden Its Programs

Oct. 4, 2006

By Aaron Lorenzo

MacroGenics Gets $63M From Government, Mostly For WNV

Oct. 4, 2006

By Aaron Lorenzo

PTC Therapeutics Earns $17M For Bioterror Work

Oct. 3, 2006

By Aaron Lorenzo

IOM report: Drug safety issues point to FDA fund ‘imbalance’

Oct. 3, 2006

By Aaron Lorenzo

PTC Therapeutics Earns $17M For Bioterror Work

Oct. 3, 2006

By Aaron Lorenzo

Antiviral Maribavir Moves Into Pivotal Development

Oct. 2, 2006

By Aaron Lorenzo

IOM Report: Poor Funding Cause For Concern At FDA

Oct. 2, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
First-in-class non-β-lactam targeting AMR gram-negative pathogens
BioWorld Science
Antimicrobial resistance (AMR) is increasingly compromising the effectiveness of essential antibiotics, resulting in higher global mortality and morbidity rates....